Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Omega Diagnostics ( (GB:CNSL) ) has issued an update.
Cambridge Nutritional Sciences plc has announced it will release its Half Year results for the six months ended 30 September 2025 on 10 November 2025. The company will host a live online presentation for shareholders and potential investors on the same day to discuss the results, providing an opportunity for engagement and transparency with stakeholders.
The most recent analyst rating on (GB:CNSL) stock is a Hold with a £3.00 price target. To see the full list of analyst forecasts on Omega Diagnostics stock, see the GB:CNSL Stock Forecast page.
Spark’s Take on GB:CNSL Stock
According to Spark, TipRanks’ AI Analyst, GB:CNSL is a Neutral.
Omega Diagnostics’ overall stock score reflects a challenging financial and technical outlook. The most significant factor is the mixed financial performance, with profitability overshadowed by declining revenue and cash flow issues. Technical analysis indicates bearish momentum, further weighing down the score. The stock’s valuation suggests it may be undervalued, providing a potential opportunity for value investors.
To see Spark’s full report on GB:CNSL stock, click here.
More about Omega Diagnostics
Cambridge Nutritional Sciences plc is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Average Trading Volume: 252,874
Technical Sentiment Signal: Strong Sell
Current Market Cap: £6.31M
See more data about CNSL stock on TipRanks’ Stock Analysis page.